AEA decreases mPGES-1 mRNA and protein levels. by Claudia A. Vercelli (284964)

Inhibition of RhoA kinase (ROK) decreases vitreous enhancement of Ad TGE and vitreous enhancement of TGE. by Alice Liu (4814415)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

Levels of the antioxidant enzyme, MnSOD are decreased in the cortical and hippocampal microvessels. by Susan A. Austin (768265)

The AMPK inhibitor CC exacerbates palmitate-induced decreases in viability. by Dustin M. Lee (8207457)

Transaldolase deficiency causes a starvation-like response that decreases animal fat content and rewires lipid metabolism gene expression. by Christopher F. Bennett (3875731)

“…<p><b>(A)</b> Intestinal fat staining decreases from RNAi knockdown of <i>tald-1</i> or <i>cco-1</i>. …”

CC-1⁺ immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1⁺ oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”

Effect of 1N11 on aPL impairment of trophoblast migration and proliferation, and aPL-induced fetal resorption. by Chieko Mineo (725831)

Subjects:

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

Decreased brain-derived neurotrophic factor plasma levels in psoriasis patients by A.R. Brunoni (5694239)

“…Our finding, that BDNF is decreased in psoriasis, supports the concept of a brain-skin connection in psoriasis. …”

Effect of 1N11 on cultured endothelial cell migration impairment by 3F8 or aPL, and on aPL blunting of carotid artery reendothelialization in vivo. by Chieko Mineo (725831)

Subjects:

Effect of 1N11 on thrombus formation induced by aPL in mice. by Chieko Mineo (725831)

Subjects:

The role of ULK1-11A/ATG13-4A unphosphorylatable mutant in cell cycle progression. by Zhiyuan Li (205620)

Timeline of the decrease in FVD and increase in D_V after EP and ECT. by Bostjan Markelc (385700)

Microparticles (MPs) from CD patients decrease 5-HT contraction in mouse aorta. by Daniela Leonetti (447114)

M1 protein with T37A mutation confers increased pathogenicity and replication of H9N2 virus in mice. by Chenxi Wang (284364)

Subjects:

csBAP31-positive cells show decreased survival. by Se-Ri Seo (4597801)